Skip to main content
Erschienen in: Acta Diabetologica 1/2010

01.03.2010 | Original Article

Profile of patients with diabetes in Eritrea: results of first phase registry analyses

verfasst von: Berhane Seyum, Goitom Mebrahtu, Abdulmumini Usman, Jacob Mufunda, Beyene Tewolde, Solomon Haile, Andrew Kosia, Ermias Negassi

Erschienen in: Acta Diabetologica | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

A cross-sectional descriptive study was done on patients recently entered into the National Diabetes Registry in Eritrea where the prevalence was estimated to be 2.2% based on patient information in 2004. Of the 627 patients with diabetes, two thirds were type 2. Although type 1 had poorer control (42.9%) than type 2 (29.9%), some of the risk factors such as cholesterol (43.4 vs. 28.2%), triglyceride (23.4 vs. 12.8%), hypertension (55.2 vs. 12.7%) as well as BMI and waist/hip ratio were higher in type 2 than type 1. More than one-third (41.2%) of patients with type 2 compared to type 1 (19.5%) had complications, the commonest being retinopathy (33%) followed by foot ulcers (14%) and neuropathy (4%). Many of the diabetic patients demonstrated the presence of the metabolic syndrome components such as hypertension, obesity and dyslipidemia. The authors conclude that diabetes registry is invaluable in providing evidence-based prevention and control of the disease.
Literatur
1.
Zurück zum Zitat Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann New York Acad Sci 1084:1–29CrossRef Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann New York Acad Sci 1084:1–29CrossRef
2.
Zurück zum Zitat Mbanya JC, Sobngwi E (2003) Diabetes in Africa diabetes micro vascular and macro vascular disease in Africa. J Cardiovasc Risk 10:97–102CrossRefPubMed Mbanya JC, Sobngwi E (2003) Diabetes in Africa diabetes micro vascular and macro vascular disease in Africa. J Cardiovasc Risk 10:97–102CrossRefPubMed
3.
Zurück zum Zitat Mufunda J, Nyarango P, Kosia A, Ogbamariam A, Mebrahtu G, Usman A et al (2005) Non-communicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens 19:255–256PubMed Mufunda J, Nyarango P, Kosia A, Ogbamariam A, Mebrahtu G, Usman A et al (2005) Non-communicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens 19:255–256PubMed
4.
Zurück zum Zitat Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J et al (2006) Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16:521–526PubMed Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J et al (2006) Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16:521–526PubMed
5.
Zurück zum Zitat Usman A, Mebrahtu G, Mufunda J, Nyarango P, Hagos G, Kosia A et al (2006) Prevalence of non communicable disease risk factors in Eritrea. Ethn Dis 16:542–546PubMed Usman A, Mebrahtu G, Mufunda J, Nyarango P, Hagos G, Kosia A et al (2006) Prevalence of non communicable disease risk factors in Eritrea. Ethn Dis 16:542–546PubMed
6.
Zurück zum Zitat Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A (2006) Prevalence of hypertension in Eritrea and its relationship with obesity: results from a national blood pressure survey. J Hum Hypertens 20(1):59–65CrossRefPubMed Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A (2006) Prevalence of hypertension in Eritrea and its relationship with obesity: results from a national blood pressure survey. J Hum Hypertens 20(1):59–65CrossRefPubMed
7.
Zurück zum Zitat Sharp P, Rainbow S (2002) Continuous glucose monitoring and hemoglobin A1C. Ann Clin Biochem 39:516–517CrossRefPubMed Sharp P, Rainbow S (2002) Continuous glucose monitoring and hemoglobin A1C. Ann Clin Biochem 39:516–517CrossRefPubMed
8.
Zurück zum Zitat Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190CrossRefPubMed Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190CrossRefPubMed
9.
Zurück zum Zitat Carinci F, Federici MO, Benedetti MM (2006) Diabetes registers and prevention strategies: towards an active use of health information. Diabetes Res Clin Pract 74(Suppl 2):S215–S219CrossRef Carinci F, Federici MO, Benedetti MM (2006) Diabetes registers and prevention strategies: towards an active use of health information. Diabetes Res Clin Pract 74(Suppl 2):S215–S219CrossRef
10.
Zurück zum Zitat Georgioou A, Burns J, McKenzie S, Penn D, Flack J, Harris MF (2006) Monitoring change in diabetes care using diabetes registers-experience from divisions of general practice. Aust Fam Phys 35:77–80 Georgioou A, Burns J, McKenzie S, Penn D, Flack J, Harris MF (2006) Monitoring change in diabetes care using diabetes registers-experience from divisions of general practice. Aust Fam Phys 35:77–80
11.
Zurück zum Zitat Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P (2006) Increased prevalence of micro vascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8:424–425 Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P (2006) Increased prevalence of micro vascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8:424–425
12.
Zurück zum Zitat Swai AB, Kitange HM, Masuki G, Kilima PM, Alberti KG, McLarty DG (1992) Is diabetes mellitus related to undernutrition in rural Tanzania? BMJ 305:1057–1062CrossRefPubMed Swai AB, Kitange HM, Masuki G, Kilima PM, Alberti KG, McLarty DG (1992) Is diabetes mellitus related to undernutrition in rural Tanzania? BMJ 305:1057–1062CrossRefPubMed
13.
Zurück zum Zitat Cuissnier-Raynall JC, Ducorps M, Grandpierre G (1985) Tropical diabetes mellitus, a new nutritional indicator. Med Trop 45:179–184 Cuissnier-Raynall JC, Ducorps M, Grandpierre G (1985) Tropical diabetes mellitus, a new nutritional indicator. Med Trop 45:179–184
14.
Zurück zum Zitat Sleight P, Pouleur H, Zannad F (2006) Benefits, challenges, and registrability of the polypill. Eur Heart J 27:1651–1656CrossRefPubMed Sleight P, Pouleur H, Zannad F (2006) Benefits, challenges, and registrability of the polypill. Eur Heart J 27:1651–1656CrossRefPubMed
15.
Zurück zum Zitat Gaziano TA, Opie LH, Weinsterin MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679–686CrossRefPubMed Gaziano TA, Opie LH, Weinsterin MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679–686CrossRefPubMed
16.
Zurück zum Zitat Siraj ES, Sevoum B, Saenz C, Abdulkadir J (2006) Lipid and lipoprotein profiles in Ethiopians with diabetes mellitus. Metabolism 55:706–710CrossRefPubMed Siraj ES, Sevoum B, Saenz C, Abdulkadir J (2006) Lipid and lipoprotein profiles in Ethiopians with diabetes mellitus. Metabolism 55:706–710CrossRefPubMed
17.
Zurück zum Zitat Kulenovic I, Rasic S, Karcic S (2006) Development of micro vascular complications in type 1 diabetic patients 10 years follow up. Bosn J Basic Med Sci 6:47–50PubMed Kulenovic I, Rasic S, Karcic S (2006) Development of micro vascular complications in type 1 diabetic patients 10 years follow up. Bosn J Basic Med Sci 6:47–50PubMed
18.
Zurück zum Zitat Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N (2007) Contribution of nitric oxide to cutaneous micro vascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292:E314–E318CrossRefPubMed Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N (2007) Contribution of nitric oxide to cutaneous micro vascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292:E314–E318CrossRefPubMed
19.
Zurück zum Zitat Kasaloya Z, Prazny M, Skrha J (2006) Relationship between peripheral diabetic neuropathy and micro vascular reactivity in patients with type 1 and type 2 diabetes mellitus—neuropathy and microcirculation. Exp Clin Endocrinol Diabet 114:52–57CrossRef Kasaloya Z, Prazny M, Skrha J (2006) Relationship between peripheral diabetic neuropathy and micro vascular reactivity in patients with type 1 and type 2 diabetes mellitus—neuropathy and microcirculation. Exp Clin Endocrinol Diabet 114:52–57CrossRef
20.
Zurück zum Zitat Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O (2006) An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5:244–249CrossRefPubMed Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O (2006) An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5:244–249CrossRefPubMed
Metadaten
Titel
Profile of patients with diabetes in Eritrea: results of first phase registry analyses
verfasst von
Berhane Seyum
Goitom Mebrahtu
Abdulmumini Usman
Jacob Mufunda
Beyene Tewolde
Solomon Haile
Andrew Kosia
Ermias Negassi
Publikationsdatum
01.03.2010
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2010
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0093-8

Weitere Artikel der Ausgabe 1/2010

Acta Diabetologica 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.